Authors: Lundberg, P Lundgren, I Mukohyama, H Lehenkari, PP Horton, MA Lerner, UH

Citation: P. Lundberg et al., Vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activatingpeptide receptor subtypes in mouse calvarial osteoblasts: Presence of VIP-2 receptors and differentiation-induced expression of VIP-1 receptors, ENDOCRINOL, 142(1), 2001, pp. 339-347

Authors: Ransjo, M Lie, A Mukohyama, H Lundberg, P Lerner, UH

Citation: M. Ransjo et al., Microisolated mouse osteoclasts express VIP-1 and PACAP receptors, BIOC BIOP R, 274(2), 2000, pp. 400-404

Authors: Mukohyama, H Ransjo, M Taniguchi, H Ohyama, T Lerner, UH

Citation: H. Mukohyama et al., The inhibitory effects of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide on osteoclast formation are associatedwith upregulation of osteoprotegerin and downregulation of RANKL and RANK, BIOC BIOP R, 271(1), 2000, pp. 158-163

Authors: Lundberg, P Bostrom, I Mukohyama, H Bjurholm, A Smans, K Lerner, UH

Citation: P. Lundberg et al., Neuro-hormonal control of bone metabolism: vasoactive intestinal peptide stimulates alkaline phosphatase activity and mRNA expression in mouse calvarial osteoblasts as well as calcium accumulation mineralized bone nodules, REGUL PEPT, 85(1), 1999, pp. 47-58